Trial Profile
Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Aged 3-5 Months: A Phase 3 Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Hib-meningococcal vaccine groups A and C conjugate (Primary) ; Hib vaccine; Meningococcal vaccine groups A and C polysaccharide
- Indications Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections
- Focus Pharmacodynamics
- 30 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Apr 2012 New trial record